PURPOSE: Massive hemoptysis is a life threatening situation with high mortality rates. Surgery is effective, however generally an avoided treatment. We report our experience with patients undergoing lung resection for life-threatening hemoptysis. METHODS: Records of all surgically treated patients for hemoptysis between June 2009 and June 2012 were reviewed and analyzed retrospectively. RESULTS: Anatomical resection was performed on 31 (15.3%) patients out of 203 patients referred to our intensive care unit for life-threatening hemoptysis. 25 (80.6%) were male and six (19.4%) were female; with mean age of 46.4 ± 13.7 (21-77). Pneumonectomy was performed in four (12.9%), lobectomy in 24 (77.4%), segmentectomy in two (6.5%) and bilobectomy in one case. Postoperative complications developed in eight (25.8%), and mortality was observed in two (6.5%) patients. Etiology was bronchiectasis in 13 (42.0%), tuberculosis in eight (25.8%), carcinoma in four (12.9%), aspergilloma in four (12.9%), hydatid cyst in one (3.2%) and lung abscess in one (3.2%) of the cases. CONCLUSIONS: Although lung resection in the treatment of massive hemoptysis is accompanied with high morbidity and mortality rates, surgery is the only permanent curative modality. Acceptable results can be achived in the company of a multidisciplinary approach, through avoidance of pneumonectomy and urgent surgery.
PURPOSE: Massive hemoptysis is a life threatening situation with high mortality rates. Surgery is effective, however generally an avoided treatment. We report our experience with patients undergoing lung resection for life-threatening hemoptysis. METHODS: Records of all surgically treated patients for hemoptysis between June 2009 and June 2012 were reviewed and analyzed retrospectively. RESULTS: Anatomical resection was performed on 31 (15.3%) patients out of 203 patients referred to our intensive care unit for life-threatening hemoptysis. 25 (80.6%) were male and six (19.4%) were female; with mean age of 46.4 ± 13.7 (21-77). Pneumonectomy was performed in four (12.9%), lobectomy in 24 (77.4%), segmentectomy in two (6.5%) and bilobectomy in one case. Postoperative complications developed in eight (25.8%), and mortality was observed in two (6.5%) patients. Etiology was bronchiectasis in 13 (42.0%), tuberculosis in eight (25.8%), carcinoma in four (12.9%), aspergilloma in four (12.9%), hydatid cyst in one (3.2%) and lung abscess in one (3.2%) of the cases. CONCLUSIONS: Although lung resection in the treatment of massive hemoptysis is accompanied with high morbidity and mortality rates, surgery is the only permanent curative modality. Acceptable results can be achived in the company of a multidisciplinary approach, through avoidance of pneumonectomy and urgent surgery.
Authors: Claire Andréjak; Antoine Parrot; Bernard Bazelly; Pierre Yves Ancel; Michel Djibré; Antoine Khalil; Dominique Grunenwald; Muriel Fartoukh Journal: Ann Thorac Surg Date: 2009-11 Impact factor: 4.330
Authors: Karen L Swanson; C Michael Johnson; Udaya B S Prakash; Michael A McKusick; James C Andrews; Anthony W Stanson Journal: Chest Date: 2002-03 Impact factor: 9.410
Authors: Jacques Jougon; Michel Ballester; Frédéric Delcambre; Tarun Mac Bride; Philippe Valat; Francis Gomez; François Laurent; Jean François Velly Journal: Eur J Cardiothorac Surg Date: 2002-09 Impact factor: 4.191
Authors: Mark J Schuuring; Peter I Bonta; Michele van Vugt; Frank Smithuis; Otto M van Delden; Jouke T Annema; Kees Stijnis Journal: Respiration Date: 2016-10-20 Impact factor: 3.580
Authors: Ju Sik Yun; Sang Yun Song; Kook Joo Na; Seok Kim; Keun-Ho Jang; In Seok Jeong; Sang Gi Oh Journal: J Thorac Dis Date: 2018-06 Impact factor: 2.895